The effects of 17-β estradiol on enhancing proliferation of human bone marrow mesenchymal stromal cells in vitro

Stem Cells and Development

Volumn 20, Issue 5, 2011, Pages 925-931

  Hong, Liu ^a   Zhang, Guoquan ^b   Sultana, Habiba ^c   Yu, Yang ^a   Wei, Zhen ^b  

^a UNIVERSITY OF IOWA   (United States)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; TELOMERASE;

ADIPOGENESIS; ADULT; ARTICLE; BONE DEVELOPMENT; CELL PROLIFERATION; CELL SURFACE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; STROMA CELL;

ADIPOGENESIS; ADULT; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; ESTRADIOL; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELLS; OSTEOGENESIS; REGENERATIVE MEDICINE; SEX FACTORS; STROMAL CELLS; TELOMERASE; TISSUE ENGINEERING;

EID: 79955759383     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0125     Document Type: Article

References (39)

1. Barrilleaux B, DG Phinney, DJ Prockop and KC O'Connor. (2006). Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 12:3007-3019. (Pubitemid 44846407)
2. Caplan AI. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347. (Pubitemid 47509711)
3. Eberli D and A Atala. (2006). Tissue engineering using adult stem cells. Methods Enzymol 420:287-302. (Pubitemid 44856796)
4. Perova MD, MG Shubich, VB Karpiuk, AV Fomicheva and EA Mel'nik. (2007). Using stromal stem cells for the periodontal tissue regeneration and their interaction with tissue microenvironment. Morfologiia 131:7-15.
5. Levicar N, I Dimarakis, C Flores, J Tracey, MY Gordon and NA Habib. (2007). Stem cells as a treatment for chronic liver disease and diabetes. Handb Exp Pharmacol 180:243-262.
6. Tang Y, T Yasuhara, K Hara, N Matsukawa, M Maki, G Yu, et al. (2007). Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. Cell Transplant 16: 159-169. (Pubitemid 46668790)
7. Marie PJ and O Fromigue. (2006). Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1:539-548.
8. Sethe S, Scutt A and Stolzing A. (2006). Aging of mesenchymal stem cells. Ageing Res Rev 5:91-116. (Pubitemid 43139669)
9. Bonab MM, K Alimoghaddam, F Talebian, SH Ghaffari, Ghavamzadeh A and B Nikbin. (2006). Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7:7-14.
10. Stenderup K, J Justesen, C Clausen and M Kassem. (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33:919-926. (Pubitemid 37543568)
11. Mendes SC, JM Tibbe, M Veenhof, K Bakker, S Both, PP Platenburg, et al. (2002). Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 8:911-920. (Pubitemid 35397237)
12. Baxter MA, RF Wynn, SN Jowitt, JE Wraith, LJ Fairbairn and I Bellantuono. (2004). Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22:675-682. (Pubitemid 39172200)
13. Wang Q, JH Yu, HH Zhai, QT Zhao, JW Chen, L Shu, DQ Li, et al. (2006). Temporal expression of estrogen receptor alpha in rat bone marrow mesenchymal stem cells. Biochem Biophys Res Commun 347:117-123. (Pubitemid 44040908)
14. Masuda H, C Kalka, T Takahashi, M Yoshida, M Wada, M Kobori, R Itoh, et al. (2007). Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 101:598-606. (Pubitemid 351325877)
15. Haczynski J, R Tarkowski, K Jarzabek, M Slomczynska, S Wolczynski, DA Magoffin, JA Jakowicki, et al. (2002). Human cultured skin fibroblasts express estrogen receptor alpha and beta. Int J Mol Med 10:149-153.
16. Hong SH, HY Nah, YJ Lee, JW Lee, JH Park, SJ Kim, JB Lee, et al. (2004). Expression of estrogen receptor-alpha and -beta, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodies. Mol Cells 18:320-325. (Pubitemid 40298027)
17. Zhou S, Y Zilberman, K Wassermann, SD Bain, Y Sadovsky and D Gazit. (2001). Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem Suppl Suppl 36:144-155.
18. Waters KM, DJ Rickard, BL Riggs, S Khosla, JA Katzenellenbogen, BS Katzenellenbogen, J Moore, et al. (2001). Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J Cell Biochem 83:448-462. (Pubitemid 33027489)
19. Holzer G, TA Einhorn and RJ Majeska. (2002). Estrogen regulation of growth and alkaline phosphatase expression by cultured human bone marrow stromal cells. J Orthop Res 20:281-288. (Pubitemid 34218272)
20. Hong L, A Colpan, IA Peptan, J Daw, George A and CA Evans. (2007). 17-Beta estradiol enhances osteogenic and adipogenic differentiation of human adipose-derived stromal cells. Tissue Eng 13:1197-1203. (Pubitemid 46986720)
21. Hong L, A Colpan and IA Peptan. (2006). Modulations of 17- beta estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells. Tissue Eng 12:2747-2753. (Pubitemid 46141243)
22. DiSilvio L, J Jameson, Z Gamie, PV Giannoudis and E Tsiridis. (2006). In vitro evaluation of the direct effect of estradiol on human osteoblasts (HOB) and human mesenchymal stem cells (h-MSCs). Injury 37:S33-S42. (Pubitemid 46127413)
23. Sato R, C Maesawa, K Fujisawa, K Wada, K Oikawa, Y Takikawa, et al. (2004). Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis. Gut 53:1001-1009. (Pubitemid 38824160)
24. Lee DC, JA Im, JH Kim, HR Lee and JY Shim. (2005). Effect of long-term hormone therapy on telomere length in postmenopausal women. Yonsei Med J 46:471-479.
25. Imanishi T, T Hano T and I Nishio. (2005). Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens 23:1699-1706. (Pubitemid 41233430)
26. Ling S, L Zhou, H Li, A Dai, JP Liu, et al. (2006). Effects of 17beta-estradiol on growth and apoptosis in human vascular endothelial cells: influence of mechanical strain and tumor necrosis factor-alpha. Steroids 71:799-808. (Pubitemid 44062602)
27. Imanishi T, T Hano and I Nishio. (2005). Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells. Hypertens Res 28:263-271. (Pubitemid 40812612)
28. Cha Y, SJ Kwon, W Seol and KS Park. (2008). Estrogen receptor- alpha mediates the effects of estradiol on telomerase activity in human mesenchymal stem cells. Mol Cells 26: 454-458.
29. von Stechow D, D Zurakowski, AR Pettit, R Muller, G Gronowicz, M Chorev, et al. (2004). Differential transcriptional effects of PTH and estrogen during anabolic bone formation. J Cell Biochem 93:476-490. (Pubitemid 44264183)
30. Hong L, H Sultana, K Paulius and G Zhang. (2009). Steroid regulation of proliferation and osteogenic differentiation of bone marrow stromal cells: a gender difference. J Steroid Biochem Mol Biol 114:180-185.
31. Tosi LL, BD Boyan and AL Boskey. (2005). Does sex matter in musculoskeletal health? The influence of sex and gender on musculoskeletal health. J Bone Joint Surg Am 87:1631-1647. (Pubitemid 40917768)
32. Oz OK, JE Zerwekh, C Fisher, K Graves, L Nanu, R Millsaps and ER Simpson. (2000). Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res 15:507-514. (Pubitemid 30134095)
33. Dennison E, H Syddall, C Fall, ML Brandi and C Cooper; Hertfordshire Cohort Study Group. (2005). Evidence of sexual dimorphism in relationships between estrogen receptor polymorphisms and bone mass: the Hertfordshire study. J Rheumatol 32:2400-2404. (Pubitemid 41780654)
34. Weiland NG, C Orikasa, S Hayashi and BS McEwen. (1997). Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. J Comp Neurol 388:603-612. (Pubitemid 27481295)
35. Sukhu B, B Rotenberg, C Binkert, H Kohno, R Zohar, CA McCulloch and HC Tenenbaum. (1997). Tamoxifen attenuates glucocorticoid actions on bone formation in vitro. Endocrinology 138:3269-3275. (Pubitemid 27345678)
36. Gaub MP, M Bellard, I Scheuer, P Chambon and P Sassone- Corsi. (1990). Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 63: 1267-1276. (Pubitemid 120035075)
37. Webb P, GN Lopez, RM Uht and PJ Kushner. (1995). Tamoxifen activation of the estrogen receptor=AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456.
38. Ponta H, AC Cato and P Herrlich. (1992). Interference of pathway specific transcription factors. Biochim Biophys Acta 1129:255-261.
39. Mattsson C and T Olsson. (2007). Estrogens and glucocorticoid hormones in adipose tissue metabolism. Curr Med Chem 14:2918-2924. (Pubitemid 350201658)